In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...

Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

Scientists believe a fasting-mimicking diet may boost the effects of chemotherapy and make it less grueling. A woman shares ...

New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of ...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...

Those born between 1965 and 1996 are now at greater risk from 17 different cancers. Here’s how to reduce your risk ...

SINGAPORE: Using a novel “spray” to administer chemotherapy drugs beyond the protective membrane surrounding the abdomen ...

The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

In Western countries, the current standard of care for resectable gastric cancer is perioperative chemotherapy. Preoperative chemoradiotherapy has been considered, but data are limited regarding ...

Excessive alcohol use may be one factor behind an increase in at least six cancers, including head and neck, esophageal, ...